Case report: Failure under azithromycin treatment in a case of bacteremia due to Salmonella enterica Paratyphi A

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Kobayashi, Tetsuro ^a   Hayakawa, Kayoko ^a   Mawatari, Momoko ^a   Mezaki, Kazuhisa ^a   Takeshita, Nozomi ^a   Kutsuna, Satoshi ^a   Fujiya, Yoshihiro ^a   Kanagawa, Shuzo ^a   Ohmagari, Norio ^a   Kato, Yasuyuki ^a   Morita, Masatomo ^b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Azithromycin; Enteric fever; Returned traveler; Salmonella Paratyphi; Treatment failure

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; NALIDIXIC ACID;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; CASE REPORT; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEVER; HOSPITAL READMISSION; HUMAN; INDIA; JAPANESE (PEOPLE); MALE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATIENT COMPLIANCE; RELAPSE; SALMONELLA PARATYPHI; TRAVEL; TYPHOID FEVER; ANAMNESIS; ANTIBIOTIC RESISTANCE; CLINICAL FEATURE; FOLLOW UP; JAPAN; PARATYPHOID FEVER; REPEATED DRUG DOSE; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BACTEREMIA; CEFTRIAXONE; HUMANS; INDIA; JAPAN; MALE; MIDDLE AGED; PARATYPHOID FEVER; SALMONELLA PARATYPHI A; TRAVEL; TREATMENT FAILURE;

EID: 84904446834     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-404     Document Type: Article

References (21)

1. Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ 2004, 82:346-353.
2. Humphries RM, Fang FC, Aarestrup FM, Hindler JA. In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards. Clin Infect Dis 2012, 55:1107-1113.
3. Leder K, Torresi J, Libman MD, Cramer JP, Castelli F, Schlagenhauf P, Wilder-Smith A, Wilson ME, Keystone JS, Schwartz E, Barnett ED, von Sonnenburg F, Brownstein JS, Cheng AC, Sotir MJ, Esposito DH, Freedman DO, . GeoSentinel Surveillance Network GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med 2013, 158:456-468. GeoSentinel Surveillance Network.
4. Threlfall EJ, de Pinna E, Day M, Lawrence J, Jones J. Alternatives to ciprofloxacin use for enteric fever, United Kingdom. Emerg Infect Dis 2008, 14:860-861.
5. Clinical and Laboratory Standards Institute M100-23 Performance Standards for Antimicrobial Susceptibility Testing. 2013, Twenty-Third Informational Supplement Wayne, PA, Clinical and Laboratory Standards Institute.
6. The European Committee on Antimicrobial Susceptibility Testing (EUCAST) Breakpoint Tables for Interpretation of MICs and Zone Diameters Version 3.1. 2013, Available at: [http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_3.1.pdf]. Accessed February 12, 2014, The European Committee on Antimicrobial Susceptibility Testing (EUCAST).
7. Butler T, Sridhar CB, Daga MK, Pathak K, Pandit RB, Khakhria R, Potkar CN, Zelasky MT, Johnson RB. Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother 1999, 44:243-250.
8. Parry CM, Ho VA, le Phuong T, Bay PV, Lanh MN, le Tung T, Tham NT, Wain J, Hien TT, Farrar JJ. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 2007, 51:819-825.
9. Girgis NI, Butler T, Frenck RW, Sultan Y, Brown FM, Tribble D, Khakhria R. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 1999, 43:1441-1444.
10. Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, Diep TS, Wain J, White NJ, Farrar JJ. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother 2000, 44(7):1855-1859.
11. Dolecek C, Tran TP, Nguyen NR, Le TP, Ha V, Phung QT, Doan CD, Nguyen TB, Duong TL, Luong BH, Nguyen TB, Nguyen TA, Pham ND, Mai NL, Phan VB, Vo AH, Nguyen VM, Tran TT, Tran TC, Schultsz C, Dunstan SJ, Stepniewska K, Campbell JI, To SD, Basnyat B, Nguyen VV, Nguyen VS, Nguyen TC, Tran TH, Farrar J. A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS One 2008, 3(5):e2188.
12. Bhan MK, Bahl R, Bhatnagar S. Typhoid and paratyphoid fever. Lancet 2005, 366:749-762.
13. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison's principles of internal medicine. Enteric (Typhoid) Fever. Volume 2 2011, 1277. New York: McGraw Hill, 18.
14. Effa EE, Lassi ZS, Critchley JA, Garner P, Sinclair D, Olliaro PL, Bhutta ZA. Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev 2011, (10). doi:10.1002/14651858.CD004530.pub4.
15. Molloy A, Nair S, Cooke FJ, Wain J, Farrington M, Lehner PJ, Torok ME. First report of Salmonella enterica serotype paratyphi A azithromycin resistance leading to treatment failure. J Clin Microbiol 2010, 48:4655-4657.
16. Fernando S, Molland JG, Gottlieb T. Failure of oral antibiotic therapy, including azithromycin, in the treatment of a recurrent breast abscess caused by Salmonella enterica serotype Paratyphi A. Pathog Glob Health 2012, 106(6):366-369.
17. Foulds G, Luke DR, Teng R, Willavize SA, Friedman H, Curatolo WJ. The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension. J Antimicrob Chemother 1996, 37:37-44.
18. Panteix G, Guillaumond B, Harf R, Desbos A, Sapin V, Leclercq M, Perrin-Fayolle M. In-vitro concentration of azithromycin in human phagocytic cells. J Antimicrob Chemother 1993, 31:1-4.
19. Capoor MR, Rawat D, Nair D, Hasan AS, Deb M, Aggarwal P, Pillai P. In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever. J Med Microbiol 2007, 56:1490-1494.
20. Hassing RJ, Goessens WH, van Pelt W, Mevius DJ, Stricker BH, Molhoek N, Verbon A, van Genderen PJ. Salmonella subtypes with increased MICs for azithromycin in travelers returned to The Netherlands. Emerg Infect Dis 2014, 20(4):705-708.
21. Kraus MD, Amatya B, Kimula Y. Histopathology of typhoid enteritis: morphologic and immunophenotypic findings. Mod Pathol 1999, 12(10):949-955.